Systemic Brucellosis with Arrhythmogenic Cardiac Inflammatory Pseudotumor

29 July 2022 : Case report Poland

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare coexistence of disease or pathology

Krzysztof Kaczmarek

^1ABCDEF*, Romuald Wojnicz^2CDE, Paweł Ptaszyński^1BD, Jerzy Krzysztof Wranicz^1BD, Iwona Cygankiewicz^1BCDE

DOI: 10.12659/AJCR.935259

Am J Case Rep 2022; 23:e935259

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 2. Timeline of the present case report.

Sep 4–18, 2015
Sep 18–Dec 24, 2015
Feb–Mar, 2016
Apr 19, 2016
May 30, 2016
Jul–Sep, 2016
Nov 12, 2016
Jun–Jul, 2017
Jan–Feb, 2018
Oct 18, 2019
Feb, 2020
ECG – electrocardiogram; LAH – left anterior hemiblock; CRP – C-reactive protein; PCT – procalcitonin; CK – creatine kinase; TTE – transthoracic echocardiography; LV-EF – left ventricular ejection fraction; ETT – exertional treadmill test; MRI – magnetic resonance imaging; LV – left ventricle; USG – ultrasonography; EMB – endomyocardial biopsy; 18F-FDG PET/CT – 18F-fluorodeoxyglucose uptake on positron emission tomography scan; 24hHM-ECG – 24-hour ECG Holter Monitoring; 48hHM-ECG – 48-hour ECG Holter Monitoring; VPBs – Ventricular Premature Beats; SVPBs – Supraventricular Premature Beats; ANA – antinuclear antibodies; ANCA – antineutrophil cytoplasmic antibodies; S-ICD – subcutaneous cardioverter-defibrillator.

Back to the Article